The companies’ CAR-T seemed to cause fewer movement disorders in a multiple myeloma trial than J&J's Carvykti has in other ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Arvinas Holding Company (ARVN – Research ...

CAMBRIDGE, Mass., November 04, 2024--2seventy bio, Inc. (Nasdaq: TSVT) will announce its third quarter 2024 financial results on Tuesday, November 12, 2024. A conference call and webcast will be held ...

Azenta, Inc. will announce fiscal fourth quarter and full year 2024 earnings which ended on September 30, 2024, on Tuesday, November 12, 2024, after the market closes. The Company will host a ...

When it comes to keeping your smile bright and healthy, MySmile offers a complete range of effective, affordable, and safe oral care products. With over 10,000 5-star reviews on Amazon and TikTok, ...

Bristol-Myers Squibb (BMY) stock gained as the comany exceeded Q3 2024 financial forecasts, with strong revenue growth and ...

Today, the National Comprehensive Cancer Network is presenting preliminary data from a study evaluating the usability of the Health Equity Report Card (HERC) tool during the American Public Health ...

Growth portfolio primarily comprises sales from immuno-oncology drugs like Opdivo, Orencia, Yervoy, Reblozyl, Opdualag, ...

Shares of 2seventy bio, Inc. (NASDAQ:TSVT – Get Free Report) have received an average rating of “Moderate Buy” from the nine ...

Exchange Traded Concepts LLC lowered its holdings in 2seventy bio, Inc. (NASDAQ:TSVT – Free Report) by 36.6% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 34,816 shares of the ...